Medicare AdvantageCoverageMedium impact
Injections for Chronic Pain Conditions - Medicare Advantage (Revised)
Humana·Pain Management, Anesthesiology, Neurology +2 more·Medicare Advantage
Effective date
Feb 2, 2026
We identified it
Jun 24, 2026
Summary
Humana has updated their Medicare Advantage policy for chronic pain injections including epidural steroid injections, facet joint injections, nerve blocks, sacroiliac joint injections, and trigger point injections. This revision consolidates coverage criteria and references current Medicare Administrative Contractor (MAC) Local Coverage Determinations across all jurisdictions.
Action Required
Before February 2, 2026: Billing team must review and update chronic pain injection billing procedures to align with revised Humana Medicare Advantage policy HUM-1137-008. Verify current MAC LCD requirements for epidural steroid injections, facet joint procedures, nerve blocks, sacroiliac joint injections, and trigger point injections in your jurisdiction. Update prior authorization workflows and documentation requirements as specified in applicable MAC LCDs.